Stocksigma LogoStocksigma Logo

OneSource Specialty Pharma Re-designates Dr. Claudio Albrecht as Non-Executive Director

OneSource Specialty Pharma's Board approved the redesignation of Dr. Claudio Albrecht from Independent Director to Non-Executive Non-Independent Director

OneSource Specialty Pharma Re-designates Dr. Claudio Albrecht as Non-Executive Director

Onesource Specialty Pharma Ltd 路 Change in Management 路 27 Oct 2026, 3:43 pm

OneSource Specialty Pharma Re-designates Dr. Claudio Albrecht as Non-Executive Director OneSource Specialty Pharma's Board approved the redesignation of Dr. Claudio Albrecht from Independent Director to Non-Executive Non-Independent Director, effective 27th Oct'26, subject to shareholder approval. Dr. Albrecht brings over three decades of global pharma experience, having previously served as CEO of Ratiopharm Group, Actavis Group, and STADA AG, as well as Co-Founder and Managing Partner of Albrecht, Prock & Partners AG. The position is liable to retirement by rotation in accordance with statutory provisions.

Original exchange filing (PDF)

More announcements from Onesource Specialty Pharma Ltd

All Onesource Specialty Pharma Ltd announcements